nodes	percent_of_prediction	percent_of_DWPC	metapath
Meprobamate—ABCB1—Lisinopril—dilated cardiomyopathy	0.232	0.532	CbGbCtD
Meprobamate—ABCB1—Spironolactone—dilated cardiomyopathy	0.204	0.468	CbGbCtD
Meprobamate—Drug eruption—Spironolactone—dilated cardiomyopathy	0.0364	0.0683	CcSEcCtD
Meprobamate—Hypotensive—Furosemide—dilated cardiomyopathy	0.0334	0.0626	CcSEcCtD
Meprobamate—Anuria—Lisinopril—dilated cardiomyopathy	0.0262	0.0491	CcSEcCtD
Meprobamate—Drug eruption—Furosemide—dilated cardiomyopathy	0.0198	0.0371	CcSEcCtD
Meprobamate—Ataxia—Spironolactone—dilated cardiomyopathy	0.0153	0.0287	CcSEcCtD
Meprobamate—Eosinophilia—Spironolactone—dilated cardiomyopathy	0.0139	0.0261	CcSEcCtD
Meprobamate—Drowsiness—Spironolactone—dilated cardiomyopathy	0.0125	0.0235	CcSEcCtD
Meprobamate—Stevens-Johnson syndrome—Spironolactone—dilated cardiomyopathy	0.0124	0.0233	CcSEcCtD
Meprobamate—Agranulocytosis—Spironolactone—dilated cardiomyopathy	0.0117	0.0219	CcSEcCtD
Meprobamate—Aplastic anaemia—Furosemide—dilated cardiomyopathy	0.0114	0.0214	CcSEcCtD
Meprobamate—Erythema multiforme—Spironolactone—dilated cardiomyopathy	0.0106	0.0199	CcSEcCtD
Meprobamate—Oliguria—Lisinopril—dilated cardiomyopathy	0.00992	0.0186	CcSEcCtD
Meprobamate—Vascular purpura—Furosemide—dilated cardiomyopathy	0.00988	0.0185	CcSEcCtD
Meprobamate—Dermatitis exfoliative—Furosemide—dilated cardiomyopathy	0.00937	0.0176	CcSEcCtD
Meprobamate—Dermatitis bullous—Furosemide—dilated cardiomyopathy	0.00925	0.0174	CcSEcCtD
Meprobamate—Purpura—Furosemide—dilated cardiomyopathy	0.00917	0.0172	CcSEcCtD
Meprobamate—Leukopenia—Spironolactone—dilated cardiomyopathy	0.00876	0.0164	CcSEcCtD
Meprobamate—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.00799	0.015	CcSEcCtD
Meprobamate—Eosinophilia—Furosemide—dilated cardiomyopathy	0.00757	0.0142	CcSEcCtD
Meprobamate—Somnolence—Spironolactone—dilated cardiomyopathy	0.0071	0.0133	CcSEcCtD
Meprobamate—Drowsiness—Furosemide—dilated cardiomyopathy	0.00681	0.0128	CcSEcCtD
Meprobamate—Stevens-Johnson syndrome—Furosemide—dilated cardiomyopathy	0.00676	0.0127	CcSEcCtD
Meprobamate—Agranulocytosis—Furosemide—dilated cardiomyopathy	0.00636	0.0119	CcSEcCtD
Meprobamate—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.00631	0.0118	CcSEcCtD
Meprobamate—Ataxia—Lisinopril—dilated cardiomyopathy	0.00624	0.0117	CcSEcCtD
Meprobamate—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.00589	0.011	CcSEcCtD
Meprobamate—Erythema multiforme—Furosemide—dilated cardiomyopathy	0.00578	0.0108	CcSEcCtD
Meprobamate—Eosinophilia—Lisinopril—dilated cardiomyopathy	0.00568	0.0106	CcSEcCtD
Meprobamate—Pruritus—Spironolactone—dilated cardiomyopathy	0.00565	0.0106	CcSEcCtD
Meprobamate—Bronchospasm—Lisinopril—dilated cardiomyopathy	0.00564	0.0106	CcSEcCtD
Meprobamate—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00547	0.0103	CcSEcCtD
Meprobamate—Arrhythmia—Furosemide—dilated cardiomyopathy	0.00546	0.0102	CcSEcCtD
Meprobamate—Dizziness—Spironolactone—dilated cardiomyopathy	0.00528	0.00991	CcSEcCtD
Meprobamate—Vomiting—Spironolactone—dilated cardiomyopathy	0.00508	0.00953	CcSEcCtD
Meprobamate—Stevens-Johnson syndrome—Lisinopril—dilated cardiomyopathy	0.00507	0.00951	CcSEcCtD
Meprobamate—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00503	0.00944	CcSEcCtD
Meprobamate—Headache—Spironolactone—dilated cardiomyopathy	0.005	0.00938	CcSEcCtD
Meprobamate—Agitation—Furosemide—dilated cardiomyopathy	0.00489	0.00918	CcSEcCtD
Meprobamate—Vertigo—Furosemide—dilated cardiomyopathy	0.00478	0.00897	CcSEcCtD
Meprobamate—Agranulocytosis—Lisinopril—dilated cardiomyopathy	0.00477	0.00895	CcSEcCtD
Meprobamate—Leukopenia—Furosemide—dilated cardiomyopathy	0.00477	0.00894	CcSEcCtD
Meprobamate—Nausea—Spironolactone—dilated cardiomyopathy	0.00474	0.0089	CcSEcCtD
Meprobamate—Oedema peripheral—Lisinopril—dilated cardiomyopathy	0.00452	0.00848	CcSEcCtD
Meprobamate—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.00435	0.00815	CcSEcCtD
Meprobamate—Erythema multiforme—Lisinopril—dilated cardiomyopathy	0.00434	0.00814	CcSEcCtD
Meprobamate—Shock—Furosemide—dilated cardiomyopathy	0.00428	0.00802	CcSEcCtD
Meprobamate—Chills—Lisinopril—dilated cardiomyopathy	0.00412	0.00772	CcSEcCtD
Meprobamate—Arrhythmia—Lisinopril—dilated cardiomyopathy	0.0041	0.00769	CcSEcCtD
Meprobamate—Hypotension—Furosemide—dilated cardiomyopathy	0.00406	0.00762	CcSEcCtD
Meprobamate—Paraesthesia—Furosemide—dilated cardiomyopathy	0.0039	0.00732	CcSEcCtD
Meprobamate—Somnolence—Furosemide—dilated cardiomyopathy	0.00386	0.00725	CcSEcCtD
Meprobamate—Angioedema—Lisinopril—dilated cardiomyopathy	0.00365	0.00685	CcSEcCtD
Meprobamate—Vertigo—Lisinopril—dilated cardiomyopathy	0.00359	0.00673	CcSEcCtD
Meprobamate—Syncope—Lisinopril—dilated cardiomyopathy	0.00358	0.00672	CcSEcCtD
Meprobamate—Leukopenia—Lisinopril—dilated cardiomyopathy	0.00358	0.00671	CcSEcCtD
Meprobamate—Palpitations—Lisinopril—dilated cardiomyopathy	0.00353	0.00662	CcSEcCtD
Meprobamate—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.00351	0.00659	CcSEcCtD
Meprobamate—Body temperature increased—Furosemide—dilated cardiomyopathy	0.00344	0.00644	CcSEcCtD
Meprobamate—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.00326	0.00612	CcSEcCtD
Meprobamate—Shock—Lisinopril—dilated cardiomyopathy	0.00321	0.00602	CcSEcCtD
Meprobamate—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.0032	0.006	CcSEcCtD
Meprobamate—Tachycardia—Lisinopril—dilated cardiomyopathy	0.00318	0.00597	CcSEcCtD
Meprobamate—Asthenia—Furosemide—dilated cardiomyopathy	0.00312	0.00585	CcSEcCtD
Meprobamate—Pruritus—Furosemide—dilated cardiomyopathy	0.00307	0.00577	CcSEcCtD
Meprobamate—Hypotension—Lisinopril—dilated cardiomyopathy	0.00305	0.00571	CcSEcCtD
Meprobamate—Diarrhoea—Furosemide—dilated cardiomyopathy	0.00297	0.00558	CcSEcCtD
Meprobamate—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.00293	0.00549	CcSEcCtD
Meprobamate—Somnolence—Lisinopril—dilated cardiomyopathy	0.0029	0.00544	CcSEcCtD
Meprobamate—Dizziness—Furosemide—dilated cardiomyopathy	0.00287	0.00539	CcSEcCtD
Meprobamate—Vomiting—Furosemide—dilated cardiomyopathy	0.00276	0.00518	CcSEcCtD
Meprobamate—Dermatitis—Furosemide—dilated cardiomyopathy	0.00274	0.00513	CcSEcCtD
Meprobamate—Headache—Furosemide—dilated cardiomyopathy	0.00272	0.00511	CcSEcCtD
Meprobamate—Nausea—Furosemide—dilated cardiomyopathy	0.00258	0.00484	CcSEcCtD
Meprobamate—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.00258	0.00483	CcSEcCtD
Meprobamate—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.0024	0.00451	CcSEcCtD
Meprobamate—Asthenia—Lisinopril—dilated cardiomyopathy	0.00234	0.00439	CcSEcCtD
Meprobamate—Pruritus—Lisinopril—dilated cardiomyopathy	0.00231	0.00433	CcSEcCtD
Meprobamate—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.00223	0.00418	CcSEcCtD
Meprobamate—Dizziness—Lisinopril—dilated cardiomyopathy	0.00216	0.00404	CcSEcCtD
Meprobamate—Vomiting—Lisinopril—dilated cardiomyopathy	0.00207	0.00389	CcSEcCtD
Meprobamate—Dermatitis—Lisinopril—dilated cardiomyopathy	0.00205	0.00385	CcSEcCtD
Meprobamate—Headache—Lisinopril—dilated cardiomyopathy	0.00204	0.00383	CcSEcCtD
Meprobamate—Nausea—Lisinopril—dilated cardiomyopathy	0.00194	0.00363	CcSEcCtD
Meprobamate—ABCB1—ABC-family proteins mediated transport—ABCC9—dilated cardiomyopathy	0.000573	0.0189	CbGpPWpGaD
Meprobamate—GABRA1—SIDS Susceptibility Pathways—SCN5A—dilated cardiomyopathy	0.000548	0.0181	CbGpPWpGaD
Meprobamate—GABRA6—Ion channel transport—RYR2—dilated cardiomyopathy	0.000525	0.0173	CbGpPWpGaD
Meprobamate—GABRA4—Ion channel transport—RYR2—dilated cardiomyopathy	0.000519	0.0171	CbGpPWpGaD
Meprobamate—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.000512	0.0169	CbGpPWpGaD
Meprobamate—GABRA6—Ion channel transport—PLN—dilated cardiomyopathy	0.000511	0.0168	CbGpPWpGaD
Meprobamate—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.000505	0.0167	CbGpPWpGaD
Meprobamate—GABRA4—Ion channel transport—PLN—dilated cardiomyopathy	0.000504	0.0166	CbGpPWpGaD
Meprobamate—GABRA5—Ion channel transport—RYR2—dilated cardiomyopathy	0.000461	0.0152	CbGpPWpGaD
Meprobamate—GABRA3—Ion channel transport—RYR2—dilated cardiomyopathy	0.000452	0.0149	CbGpPWpGaD
Meprobamate—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.000449	0.0148	CbGpPWpGaD
Meprobamate—GABRA5—Ion channel transport—PLN—dilated cardiomyopathy	0.000448	0.0148	CbGpPWpGaD
Meprobamate—GABRA2—Ion channel transport—RYR2—dilated cardiomyopathy	0.000445	0.0147	CbGpPWpGaD
Meprobamate—GABRB3—Ion channel transport—RYR2—dilated cardiomyopathy	0.000442	0.0146	CbGpPWpGaD
Meprobamate—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.000441	0.0145	CbGpPWpGaD
Meprobamate—GABRA3—Ion channel transport—PLN—dilated cardiomyopathy	0.00044	0.0145	CbGpPWpGaD
Meprobamate—GABRG2—Ion channel transport—RYR2—dilated cardiomyopathy	0.000434	0.0143	CbGpPWpGaD
Meprobamate—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.000433	0.0143	CbGpPWpGaD
Meprobamate—GABRA2—Ion channel transport—PLN—dilated cardiomyopathy	0.000433	0.0143	CbGpPWpGaD
Meprobamate—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.00043	0.0142	CbGpPWpGaD
Meprobamate—GABRB3—Ion channel transport—PLN—dilated cardiomyopathy	0.00043	0.0142	CbGpPWpGaD
Meprobamate—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.000423	0.0139	CbGpPWpGaD
Meprobamate—GABRG2—Ion channel transport—PLN—dilated cardiomyopathy	0.000422	0.0139	CbGpPWpGaD
Meprobamate—GABRA1—SIDS Susceptibility Pathways—RYR2—dilated cardiomyopathy	0.000391	0.0129	CbGpPWpGaD
Meprobamate—GABRA6—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.000385	0.0127	CbGpPWpGaD
Meprobamate—GABRA4—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00038	0.0125	CbGpPWpGaD
Meprobamate—GABRA1—Ion channel transport—RYR2—dilated cardiomyopathy	0.000379	0.0125	CbGpPWpGaD
Meprobamate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.000369	0.0122	CbGpPWpGaD
Meprobamate—GABRA1—Ion channel transport—PLN—dilated cardiomyopathy	0.000369	0.0122	CbGpPWpGaD
Meprobamate—CYP2C19—Melatonin metabolism and effects—ADRB1—dilated cardiomyopathy	0.000365	0.012	CbGpPWpGaD
Meprobamate—GABRA5—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.000338	0.0111	CbGpPWpGaD
Meprobamate—GABRA3—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.000331	0.0109	CbGpPWpGaD
Meprobamate—GABRA2—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.000326	0.0107	CbGpPWpGaD
Meprobamate—GABRB3—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.000324	0.0107	CbGpPWpGaD
Meprobamate—GABRG2—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.000318	0.0105	CbGpPWpGaD
Meprobamate—GABRA6—Neuronal System—ABCC9—dilated cardiomyopathy	0.000307	0.0101	CbGpPWpGaD
Meprobamate—GABRA4—Neuronal System—ABCC9—dilated cardiomyopathy	0.000304	0.01	CbGpPWpGaD
Meprobamate—GABRA6—Neuronal System—ACTN2—dilated cardiomyopathy	0.000295	0.00972	CbGpPWpGaD
Meprobamate—GABRA4—Neuronal System—ACTN2—dilated cardiomyopathy	0.000291	0.0096	CbGpPWpGaD
Meprobamate—GABRA1—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.000278	0.00916	CbGpPWpGaD
Meprobamate—GABRA5—Neuronal System—ABCC9—dilated cardiomyopathy	0.00027	0.00889	CbGpPWpGaD
Meprobamate—GABRA3—Neuronal System—ABCC9—dilated cardiomyopathy	0.000265	0.00873	CbGpPWpGaD
Meprobamate—GABRA2—Neuronal System—ABCC9—dilated cardiomyopathy	0.00026	0.00858	CbGpPWpGaD
Meprobamate—GABRB3—Neuronal System—ABCC9—dilated cardiomyopathy	0.000259	0.00853	CbGpPWpGaD
Meprobamate—GABRA5—Neuronal System—ACTN2—dilated cardiomyopathy	0.000259	0.00853	CbGpPWpGaD
Meprobamate—GABRA3—Neuronal System—ACTN2—dilated cardiomyopathy	0.000254	0.00837	CbGpPWpGaD
Meprobamate—GABRG2—Neuronal System—ABCC9—dilated cardiomyopathy	0.000254	0.00837	CbGpPWpGaD
Meprobamate—GABRA2—Neuronal System—ACTN2—dilated cardiomyopathy	0.00025	0.00823	CbGpPWpGaD
Meprobamate—GABRB3—Neuronal System—ACTN2—dilated cardiomyopathy	0.000248	0.00817	CbGpPWpGaD
Meprobamate—GABRG2—Neuronal System—ACTN2—dilated cardiomyopathy	0.000243	0.00803	CbGpPWpGaD
Meprobamate—CYP2E1—Vitamin A and Carotenoid Metabolism—CD36—dilated cardiomyopathy	0.00023	0.0076	CbGpPWpGaD
Meprobamate—GABRA1—Neuronal System—ABCC9—dilated cardiomyopathy	0.000222	0.00732	CbGpPWpGaD
Meprobamate—GABRA1—Neuronal System—ACTN2—dilated cardiomyopathy	0.000213	0.00702	CbGpPWpGaD
Meprobamate—GABRA6—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000183	0.00603	CbGpPWpGaD
Meprobamate—GABRA4—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.00018	0.00595	CbGpPWpGaD
Meprobamate—GABRA6—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000178	0.00586	CbGpPWpGaD
Meprobamate—GABRA6—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000178	0.00586	CbGpPWpGaD
Meprobamate—GABRA4—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000176	0.00579	CbGpPWpGaD
Meprobamate—GABRA4—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000176	0.00579	CbGpPWpGaD
Meprobamate—GABRA6—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000165	0.00545	CbGpPWpGaD
Meprobamate—GABRA4—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000163	0.00538	CbGpPWpGaD
Meprobamate—ABCB1—Integrated Pancreatic Cancer Pathway—PLN—dilated cardiomyopathy	0.000162	0.00535	CbGpPWpGaD
Meprobamate—CYP2C19—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.000162	0.00533	CbGpPWpGaD
Meprobamate—GABRA5—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.00016	0.00529	CbGpPWpGaD
Meprobamate—GABRB3—BDNF signaling pathway—RPS6KB1—dilated cardiomyopathy	0.00016	0.00527	CbGpPWpGaD
Meprobamate—GABRA3—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000157	0.00519	CbGpPWpGaD
Meprobamate—GABRA5—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000156	0.00514	CbGpPWpGaD
Meprobamate—GABRA5—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000156	0.00514	CbGpPWpGaD
Meprobamate—GABRA2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000155	0.0051	CbGpPWpGaD
Meprobamate—GABRB3—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000154	0.00507	CbGpPWpGaD
Meprobamate—GABRA3—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000153	0.00505	CbGpPWpGaD
Meprobamate—GABRA3—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000153	0.00505	CbGpPWpGaD
Meprobamate—GABRA1—SIDS Susceptibility Pathways—GJA1—dilated cardiomyopathy	0.000153	0.00503	CbGpPWpGaD
Meprobamate—GABRG2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000151	0.00498	CbGpPWpGaD
Meprobamate—GABRA2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000151	0.00496	CbGpPWpGaD
Meprobamate—GABRA2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000151	0.00496	CbGpPWpGaD
Meprobamate—GABRB3—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.00015	0.00493	CbGpPWpGaD
Meprobamate—GABRB3—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.00015	0.00493	CbGpPWpGaD
Meprobamate—GABRG2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000147	0.00484	CbGpPWpGaD
Meprobamate—GABRG2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000147	0.00484	CbGpPWpGaD
Meprobamate—GABRA5—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000145	0.00478	CbGpPWpGaD
Meprobamate—GABRB3—BDNF signaling pathway—RAC1—dilated cardiomyopathy	0.000144	0.00476	CbGpPWpGaD
Meprobamate—GABRA3—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000142	0.0047	CbGpPWpGaD
Meprobamate—GABRA2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.00014	0.00461	CbGpPWpGaD
Meprobamate—GABRB3—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000139	0.00458	CbGpPWpGaD
Meprobamate—GABRG2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000137	0.0045	CbGpPWpGaD
Meprobamate—ABCB1—Allograft Rejection—AGTR1—dilated cardiomyopathy	0.000136	0.0045	CbGpPWpGaD
Meprobamate—GABRA1—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	0.000132	0.00436	CbGpPWpGaD
Meprobamate—GABRA1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000132	0.00435	CbGpPWpGaD
Meprobamate—GABRA1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000128	0.00423	CbGpPWpGaD
Meprobamate—GABRA1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000128	0.00423	CbGpPWpGaD
Meprobamate—GABRA1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000119	0.00393	CbGpPWpGaD
Meprobamate—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.000116	0.00384	CbGpPWpGaD
Meprobamate—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.000115	0.00379	CbGpPWpGaD
Meprobamate—ABCB1—Allograft Rejection—IL10—dilated cardiomyopathy	0.000114	0.00377	CbGpPWpGaD
Meprobamate—ABCB1—Allograft Rejection—FASLG—dilated cardiomyopathy	0.000106	0.0035	CbGpPWpGaD
Meprobamate—GABRA6—Ion channel transport—RAF1—dilated cardiomyopathy	0.000104	0.00342	CbGpPWpGaD
Meprobamate—ABCB1—Allograft Rejection—FAS—dilated cardiomyopathy	0.000103	0.00338	CbGpPWpGaD
Meprobamate—GABRA4—Ion channel transport—RAF1—dilated cardiomyopathy	0.000102	0.00337	CbGpPWpGaD
Meprobamate—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.000102	0.00337	CbGpPWpGaD
Meprobamate—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.0001	0.00331	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.0001	0.0033	CbGpPWpGaD
Meprobamate—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	9.86e-05	0.00325	CbGpPWpGaD
Meprobamate—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	9.79e-05	0.00323	CbGpPWpGaD
Meprobamate—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	9.62e-05	0.00317	CbGpPWpGaD
Meprobamate—GABRB3—BDNF signaling pathway—RAF1—dilated cardiomyopathy	9.58e-05	0.00316	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	9.41e-05	0.0031	CbGpPWpGaD
Meprobamate—GABRA5—Ion channel transport—RAF1—dilated cardiomyopathy	9.09e-05	0.003	CbGpPWpGaD
Meprobamate—GABRA3—Ion channel transport—RAF1—dilated cardiomyopathy	8.93e-05	0.00294	CbGpPWpGaD
Meprobamate—GABRA2—Ion channel transport—RAF1—dilated cardiomyopathy	8.77e-05	0.00289	CbGpPWpGaD
Meprobamate—GABRA6—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	8.75e-05	0.00289	CbGpPWpGaD
Meprobamate—GABRB3—Ion channel transport—RAF1—dilated cardiomyopathy	8.71e-05	0.00287	CbGpPWpGaD
Meprobamate—GABRA4—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	8.64e-05	0.00285	CbGpPWpGaD
Meprobamate—GABRG2—Ion channel transport—RAF1—dilated cardiomyopathy	8.56e-05	0.00282	CbGpPWpGaD
Meprobamate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	8.41e-05	0.00277	CbGpPWpGaD
Meprobamate—GABRA5—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	7.68e-05	0.00253	CbGpPWpGaD
Meprobamate—GABRA3—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	7.54e-05	0.00249	CbGpPWpGaD
Meprobamate—GABRA1—Ion channel transport—RAF1—dilated cardiomyopathy	7.48e-05	0.00247	CbGpPWpGaD
Meprobamate—GABRA2—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	7.41e-05	0.00244	CbGpPWpGaD
Meprobamate—GABRB3—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	7.36e-05	0.00243	CbGpPWpGaD
Meprobamate—GABRG2—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	7.23e-05	0.00238	CbGpPWpGaD
Meprobamate—GABRA6—Neuronal System—RAF1—dilated cardiomyopathy	6.71e-05	0.00221	CbGpPWpGaD
Meprobamate—GABRA4—Neuronal System—RAF1—dilated cardiomyopathy	6.62e-05	0.00218	CbGpPWpGaD
Meprobamate—ABCB1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	6.62e-05	0.00218	CbGpPWpGaD
Meprobamate—ABCB1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	6.44e-05	0.00212	CbGpPWpGaD
Meprobamate—ABCB1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	6.44e-05	0.00212	CbGpPWpGaD
Meprobamate—GABRA1—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	6.32e-05	0.00208	CbGpPWpGaD
Meprobamate—ABCB1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	5.99e-05	0.00197	CbGpPWpGaD
Meprobamate—GABRA5—Neuronal System—RAF1—dilated cardiomyopathy	5.88e-05	0.00194	CbGpPWpGaD
Meprobamate—GABRA3—Neuronal System—RAF1—dilated cardiomyopathy	5.78e-05	0.0019	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—ANKRD1—dilated cardiomyopathy	5.78e-05	0.0019	CbGpPWpGaD
Meprobamate—GABRA2—Neuronal System—RAF1—dilated cardiomyopathy	5.68e-05	0.00187	CbGpPWpGaD
Meprobamate—GABRB3—Neuronal System—RAF1—dilated cardiomyopathy	5.64e-05	0.00186	CbGpPWpGaD
Meprobamate—GABRG2—Neuronal System—RAF1—dilated cardiomyopathy	5.54e-05	0.00183	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—TAZ—dilated cardiomyopathy	5.43e-05	0.00179	CbGpPWpGaD
Meprobamate—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	5.25e-05	0.00173	CbGpPWpGaD
Meprobamate—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	5.06e-05	0.00167	CbGpPWpGaD
Meprobamate—GABRA1—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	5.03e-05	0.00166	CbGpPWpGaD
Meprobamate—ABCB1—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	4.96e-05	0.00164	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—SDHA—dilated cardiomyopathy	4.91e-05	0.00162	CbGpPWpGaD
Meprobamate—GABRA1—Neuronal System—RAF1—dilated cardiomyopathy	4.84e-05	0.0016	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—ANKRD1—dilated cardiomyopathy	4.46e-05	0.00147	CbGpPWpGaD
Meprobamate—ABCB1—Allograft Rejection—TNF—dilated cardiomyopathy	4.35e-05	0.00143	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—ANKRD1—dilated cardiomyopathy	4.35e-05	0.00143	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—TAZ—dilated cardiomyopathy	4.19e-05	0.00138	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—TAZ—dilated cardiomyopathy	4.09e-05	0.00135	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—SDHA—dilated cardiomyopathy	3.79e-05	0.00125	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—SDHA—dilated cardiomyopathy	3.7e-05	0.00122	CbGpPWpGaD
Meprobamate—GABRA6—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	3.61e-05	0.00119	CbGpPWpGaD
Meprobamate—GABRA4—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	3.56e-05	0.00117	CbGpPWpGaD
Meprobamate—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	3.29e-05	0.00108	CbGpPWpGaD
Meprobamate—GABRA5—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	3.16e-05	0.00104	CbGpPWpGaD
Meprobamate—GABRA3—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	3.11e-05	0.00102	CbGpPWpGaD
Meprobamate—GABRA2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	3.05e-05	0.00101	CbGpPWpGaD
Meprobamate—GABRB3—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	3.03e-05	0.001	CbGpPWpGaD
Meprobamate—GABRG2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	2.98e-05	0.000982	CbGpPWpGaD
Meprobamate—GABRA1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	2.6e-05	0.000858	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	2.31e-05	0.000762	CbGpPWpGaD
Meprobamate—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	2.26e-05	0.000744	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	2.25e-05	0.000742	CbGpPWpGaD
Meprobamate—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	2.15e-05	0.000708	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	2.03e-05	0.000668	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—GPX1—dilated cardiomyopathy	1.33e-05	0.00044	CbGpPWpGaD
Meprobamate—ABCB1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.31e-05	0.00043	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—CD36—dilated cardiomyopathy	1.3e-05	0.000429	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—AGT—dilated cardiomyopathy	1.17e-05	0.000386	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—GPX1—dilated cardiomyopathy	1.03e-05	0.000339	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—GPX1—dilated cardiomyopathy	1e-05	0.000331	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—CD36—dilated cardiomyopathy	1e-05	0.000331	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—CD36—dilated cardiomyopathy	9.79e-06	0.000323	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—AGT—dilated cardiomyopathy	9.03e-06	0.000298	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—AGT—dilated cardiomyopathy	8.81e-06	0.000291	CbGpPWpGaD
